Analyst Upgraded Stocks on the NAS November 2024

November 13, 2024

Analyst Upgrades

Companies are upgraded when at least one analyst has upgraded their view on the stock, therefore increasing its average consensus value. Companies can get upgraded for a number of reasons, including improved future earnings potential due to new contracts, new products, cost savings or restructuring.

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

About the Data

This table includes the number of analyst ratings along with the number of buy-hold-sells on the company. A company is included in this list when its mean rating increases from the previous week.

How do you use this table?

Companies that have recently been upgraded tend to have potential for future gains. Use this table as a starting point for more research on these companies. Stocks with analyst coverage also tend to have higher visibility in the marketplace, therefore have the potential to be more liquid. Stocks in this category are generally held for capital appreciation or growth potential.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameBuyOutperformHoldUnderperformSellNo OpinionMean RatingPrev Mean LabelMean Label
AAPL Apple Inc 5 1 1 1 0 0 4.3 4.1 Outperform
PMVP PMV Pharmaceuticals Inc 2 0 0 0 0 0 5.0 4.0 Buy
All data provided as at market close November 10, 2024.

Company Details

Apple Inc

AAPL:NAS

Buy

5

Hold

1

Mean Rating

4.3

Prev Mean Rating

4.1

Mean Label

Outperform

Apple is among the largest companies in the world, with a broad portfolio of hardware and software products targeted at consumers and businesses. Apple's iPhone makes up a majority of the firm sales, and Apple's other products like Mac, iPad, and Watch are designed around the iPhone as the focal point of an expansive software ecosystem. Apple has progressively worked to add new applications, like streaming video, subscription bundles, and augmented reality.

Access the stockcalc valuation


PMV Pharmaceuticals Inc

PMVP:NAS

Buy

2

Mean Rating

5.0

Prev Mean Rating

4.0

Mean Label

Buy

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

Access the stockcalc valuation


Analysts upgraded Apple and PMV Pharma on the NAS this month. See the full list of analyst upgrades on the blog: https://www.stockcalc.com/Blog/analyst-upgraded-stocks-nas-november-2024
Apple $AAPL and PMV Pharma $PMVP upgraded on the #NAS this month. See the full list of upgrades: https://www.stockcalc.com/Blog/analyst-upgraded-stocks-nas-november-2024
Analysts upgraded Apple and PMV Pharma on the NAS this month. See the full list of analyst upgrades on the blog: https://www.stockcalc.com/Blog/analyst-upgraded-stocks-nas-november-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.